It emphasizes the need to consider these risks in psychiatric treatment and calls for a more attentive, multidisciplinary approach when prescribing ssris. This complication can be serious, with delirium, seizure, or even death. Although the patient had no symptoms attributable to hyponatremia, low serum sodium concentrations may cause malaise, weakness, confusion, impaired functional ability, and when severe,. In conclusion, the risk of recurrent hyponatremia in patients with a history of hyponatremia makes sertraline an inappropriate choice Alternative antidepressants with lower hyponatremia risk should be considered, along with careful monitoring of electrolytes if antidepressant therapy is necessary. Doctors might prescribe diuretics and vasopressin receptor antagonists for ongoing hyponatremia
These drugs help get rid of too much water and manage electrolytes. Risk stratification among individual drugs revealed that fluoxetine (ssris) and venlafaxine (snris) had the highest risk, while sertraline and duloxetine were associated with lower risks Both ssris and snris significantly increase the risk of hyponatremia, with snris posing a slightly higher risk. The fda drug label suggests that sertraline can decrease sodium levels by potentially causing the syndrome of inappropriate antidiuretic hormone secretion (siadh), leading to hyponatremia. While these medications are generally effective, they can occasionally cause rare but serious side effects, such as hyponatremia. When used to treat hyponatremia, sertraline works by inhibiting the reabsorption of sodium in the kidneys
